Saskia M. van Gastel

Ultrasound is at least as good as magnetic resonance imaging in predicting tumour size post-neoadjuvant chemotherapy in breast cancer

Birgit E. P. J. Vriens, Bart de Vries, Marc B. I. Lobbes et al. · European Journal of Cancer · 2015 · 84 citations

Medicine, Oncology, Radiology +13

Primary Granulocyte Colony-Stimulating Factor Prophylaxis During the First Two Cycles Only or Throughout All Chemotherapy Cycles in Patients With Breast Cancer at Risk for Febrile Neutropenia

Maureen J.B. Aarts, Frank Peters, Caroline M.P.W. Mandigers et al. · Journal of Clinical Oncology · 2013 · 49 citations · Full text

Medicine, Oncology, Pharmacotherapy +15

Doxorubicin/cyclophosphamide with concurrent versus sequential docetaxel as neoadjuvant treatment in patients with breast cancer

Birgit E. P. J. Vriens, Maureen J.B. Aarts, Bart de Vries et al. · European Journal of Cancer · 2013 · 43 citations

Medicine, Oncology, Pharmacology +16

Cost Effectiveness of Primary Pegfilgrastim Prophylaxis in Patients With Breast Cancer at Risk of Febrile Neutropenia

Maureen J.B. Aarts, Janneke P.C. Grutters, Frank Peters et al. · Journal of Clinical Oncology · 2013 · 42 citations

Pharmacy, Oncology, Pharmacoeconomics +13

Improved survival for sequentially as opposed to concurrently delivered neoadjuvant chemotherapy in non-metastatic breast cancer

Birgit E. P. J. Vriens, Ingeborg J. H. Vriens, Maureen J.B. Aarts et al. · Breast Cancer Research and Treatment · 2017 · 17 citations · Full text

Medicine, Oncology, Pharmacology +14